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Rowell Syndrome in Nigeria: Systemic Lupus  
Erythematosus Presenting as Recurrent Erythema 
Multiforme in a Young Woman
Dear Editor,
Systemic lupus erythematosus (SLE) is a heteroge-
neous autoimmune disease characterized by diverse 
patterns of auto-antibody production with multi-or-
gan affectation. Cutaneous involvement, either alone 
or in association with other systemic illnesses, is one 
of its most common manifestations (1). Dermatologic 
disorders like malar and discoid rashes are quite sug-
gestive of SLE. However, the occurrence of non-spe-
cific skin lesions like erythema multiforme (EM) in pa-
tients with SLE (Rowell syndrome) can rarely occur (1). 
In such patients, a diagnosis of SLE may be missed or 
delayed in the absence of other overt clinical features 
of lupus. Herein we report a case of recurring EM-like 
eruptions as the cardinal cutaneous manifestation of 
previously undiagnosed, active SLE in a young Nige-
rian woman. 
A 26-year-old Nigerian woman presented with 
a three-day history of non-pruritic, generalized, 
and target-like, erythematous annular patches and 
plaques which mostly affected the trunk. A few 
lesions had presented with crusting and erosions at 
the time of examination (Figure 1). Associated symp-
toms included oral painful ulcers, low grade fever, 
and malaise. The patient had no other systemic symp-
toms and her prior drug history was not remarkable. 
Her erythrocyte sedimentation rate (ESR) was 66 mm/
hour using the Westergren method. Screening for HIV 
and hepatitis B and C was negative. Herpes simplex, 
cytomegalovirus, and Epstein Barr viruses could not 
be screened for. Other baseline investigations (com-
plete blood count, electrolytes, urea and creatinine 
as well as urinalysis) were within normal limits. The 
patient was managed as a case of EM of an unidenti-
fied inciting agent and her symptoms resolved with 
supportive care and antibiotics. However, she devel-
oped a recurrence about 5 weeks later, with more 
extensive and coalescent skin lesions (Figure 2). Ad-
ditionally, there was a new onset of alopecia and pain 
in the small joints of the hands as well as both knees 
and ankles. At this time, the patient’s ESR had gone 
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up to 112 mm/h and she had developed significant 
proteinuria, with a protein creatinine ratio of 1.3 g/g 
(reference <0.5 g/g). Her antinuclear antibody (ANA) 
titer was high (1:320) with a speckled pattern. Anti-
Smith antibody was also positive. A renal biopsy was 
declined. A tentative diagnosis of Rowell syndrome 
was made. The patient was started on high-dose ste-
roids and hydroxychloroquine 200 mg twice daily. 
Subsequent care included the use of mycophenolate 
mofetil 1 g twice daily for 6 months. This was then 
changed to azathioprine at 50 mg twice daily. Fol-
low-up after 6 months showed sustained clearance 
of skin lesions, resolution of fever and joint pains, as 
well as improvement in the renal profile, with a urine 
protein-creatinine ratio of 0.77 g/g.
The presence of systemic lupus erythematosus, 
EM-like lesions, and a speckled pattern of antinuclear 
antibody in our patient fulfils the revised diagnostic 
criteria for RS put forward by Zeitouni et al. at the turn 
of the twenty-first century (2). 
Considering the rarity of EM-like lesions in SLE 
and the possibility of constitutional symptoms in 
EM, a diagnosis of RS may be readily overlooked in 
patients like the one described, whose major cutane-
ous manifestation of severe active SLE was EM-like 
lesions. In contrast to classic EM, where skin lesions 
are concentrated in the extremities, a predominant 
truncal distribution of EM-like lesions as found in our 
patient may favor a clinical consideration of RS (3). 
However, some authors have challenged the exis-
tence of Rowell syndrome as a distinct clinical labora-
tory entity. Arguments put forward in this regard in-
clude the fact that none of the immunological mark-
ers that have been described in RS are specific to any 
disorder. Additionally, the annular polycyclic derma-
tosis seen in sub-acute cutaneous lupus erythemato-
sus (SCLE) can be difficult to clinically and histologi-
cally differentiate from EM (4,5). Patients with SLE also 
have a higher likelihood of developing adverse drug 
reactions (6).
The inherent complexity of SLE may make for de-
layed and oftentimes difficult diagnosis, especially 
in a country where immunologic tests are expensive 
and rheumatologists are scarce. When patients do oc-
casionally present with recurrences of skin lesions in 
the spectrum of EM, Steven-Johnson syndrome, and 
toxic epidermal necrolysis in the absence of a definite 
inciting agent, undiagnosed lupus may indeed be 
present in some of these individuals and should be 
considered in the differential diagnosis.
In conclusion, while it is very rare, SLE may present 
first with recurrent episodes of EM-like rash. Despite 
the various possibilities which underlie their associa-
tion, prompt identification and treatment of SLE in 
patients presenting with EM is important to prevent 
death or irreversible organ damage.
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